HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Elena Ferrero Selected Research

Cellfood

1/2014Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Elena Ferrero Research Topics

Disease

5Neurodegenerative Diseases (Neurodegenerative Disease)
08/2020 - 01/2014
4Inflammation (Inflammations)
01/2011 - 07/2002
2Multiple Sclerosis
01/2014 - 06/2012
2Arthritis (Polyarthritis)
12/2011 - 12/2002
2Ischemia
11/2011 - 03/2006
2Neoplasms (Cancer)
10/2007 - 03/2004
2Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2007 - 03/2004
1Chronic Disease (Chronic Diseases)
08/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2016
1Atherosclerosis
10/2013
1Rheumatoid Arthritis
12/2011
1Autoimmune Diseases (Autoimmune Disease)
12/2011
1Mitochondrial Diseases (Mitochondrial Disease)
07/2011
1Bacterial Infections (Bacterial Infection)
11/2009
1Syphilis
11/2009
1Chronic Obstructive Pulmonary Disease (COPD)
06/2009
1Fever of Unknown Origin
03/2008
1Fever (Fevers)
03/2008
1Acute Kidney Injury (Acute Renal Failure)
03/2006
1Renal Insufficiency (Renal Failure)
03/2006
1Hyperalgesia
07/2005
1Heart Failure
03/2004
1Starvation
01/2003
1Pain (Aches)
12/2002

Drug/Important Bio-Agent (IBA)

5Edetic Acid (EDTA)FDA Link
08/2020 - 03/2006
5MetalsIBA
08/2020 - 07/2011
4Adenosine Triphosphate (ATP)IBA
07/2005 - 07/2002
3AluminumIBA
11/2015 - 12/2011
3Purinergic P2X7 ReceptorsIBA
10/2013 - 07/2002
3Proteins (Proteins, Gene)FDA Link
10/2007 - 01/2003
2Chelating AgentsIBA
01/2019 - 01/2014
2CalciumIBA
01/2019 - 01/2014
2Heavy MetalsIBA
06/2012 - 12/2011
2NAD (NADH)IBA
07/2011 - 01/2003
2MercuryIBA
11/2009 - 03/2008
2Chromogranin AIBA
10/2007 - 03/2004
1defibrotideIBA
01/2016
1CellfoodIBA
01/2014
1AntioxidantsIBA
01/2014
1CadmiumIBA
12/2011
1Purinergic Receptors (Receptors, Purine)IBA
01/2011
1VaccinesIBA
11/2009
1Mercury CompoundsIBA
11/2009
1salicylhydroxamic acid (SHAM)IBA
06/2009
1Dental AmalgamIBA
03/2008
1Biomarkers (Surrogate Marker)IBA
10/2007
1vasostatin IIBA
10/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2007
1SodiumIBA
03/2006
1Indomethacin (Indometacin)FDA LinkGeneric
07/2005
1Freund's AdjuvantIBA
07/2005
1periodate-oxidized adenosine 5'-triphosphateIBA
07/2005
1Diclofenac (SR 38)FDA LinkGeneric
07/2005
1CarrageenanIBA
07/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004
1Platelet Endothelial Cell Adhesion Molecule-1IBA
01/2003
1fucoidanIBA
12/2002
12',3'-dialdehyde ATPIBA
12/2002
1SelectinsIBA
12/2002
1Purinergic P2 Receptors (ADP Receptor)IBA
12/2002
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2002

Therapy/Procedure

3Chelation Therapy (Therapy, Chelation)
08/2020 - 03/2006
3Therapeutics
01/2016 - 11/2009
1Hematopoietic Stem Cell Transplantation
01/2016
1Nephrectomy
11/2011
1Intravenous Administration
07/2005
1Ligation
01/2003
1Injections
12/2002